Gado, S. Et Al. 2024. Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia. MEDICINAL CHEMISTRY .

Gado, S., Hassan, M. A., KIŞLA, M. M., & ALAGÖZ, Z., (2024). Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia. MEDICINAL CHEMISTRY .

Gado, Sarah Et Al. "Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia," MEDICINAL CHEMISTRY , 2024

Gado, Sarah Et Al. "Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia." MEDICINAL CHEMISTRY , 2024

Gado, S. Et Al. (2024) . "Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia." MEDICINAL CHEMISTRY .

@article{article, author={Sarah Gado Et Al. }, title={Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia}, journal={MEDICINAL CHEMISTRY}, year=2024}